We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Sickle Cell Pain: Intervention With Capsaicin Exposure (SPICE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03899246
Recruitment Status : Completed
First Posted : April 2, 2019
Last Update Posted : July 29, 2020
Information provided by (Responsible Party):
Alexander Glaros, Children's Hospital of Michigan

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 30, 2020
Actual Study Completion Date : March 30, 2020
Kuei N, Patel N, Xu H, et al. Characteristics and Potential Biomarkers for Chronic Pain in Patients with Sickle Cell Disease. Blood. 2015;126(23). http://www.bloodjournal.org/content/126/23/986?utm_source=TrendMD&utm_medium=cpc&utm_campaign=Blood_TrendMD_0&sso-checked=true. Accessed July 7, 2018.
Staikopoulos V, Gosnell ME, Anwer AG, Mustafa S, Hutchinson MR, Goldys EM. Hyperspectral imaging of endogenous fluorescent metabolic molecules to identify pain states in central nervous system tissue. In: Hutchinson MR, Goldys EM, eds. Vol 10013. International Society for Optics and Photonics; 2016:1001306. doi:10.1117/12.2243158